This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008;26(9):725-7.

doi: 10.2165/00019053-200826090-00002.

NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective

Julia Earnshaw, Gavin Lewis

PMID: 18767892
DOI: 10.2165/00019053-200826090-00002

Editorial

NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective

Julia Earnshaw et al. Pharmacoeconomics. 2008.

. 2008;26(9):725-7.

doi: 10.2165/00019053-200826090-00002.

Authors

Julia Earnshaw, Gavin Lewis

PMID: 18767892
DOI: 10.2165/00019053-200826090-00002

No abstract available

PubMed Disclaimer

Similar articles

Economic evaluation for pharmaceuticals in Germany.
Jönsson B. Jönsson B. Eur J Health Econ. 2007 Sep;8 Suppl 1:S1-2. doi: 10.1007/s10198-007-0066-1. Eur J Health Econ. 2007. PMID: 17638033 No abstract available.
On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
Birch S, Gafni A. Birch S, et al. Health Econ. 2002 Apr;11(3):185-91. doi: 10.1002/hec.706. Health Econ. 2002. PMID: 11921316 No abstract available.
Technology assessment in the German context.
Drummond M. Drummond M. Eur J Health Econ. 2007 Sep;8 Suppl 1:S3. doi: 10.1007/s10198-007-0067-0. Eur J Health Econ. 2007. PMID: 17619919 No abstract available.
Methods for determining cost-benefit ratios for pharmaceuticals in Germany.
von der Schulenburg J, Vauth C, Mittendorf T, Greiner W. von der Schulenburg J, et al. Eur J Health Econ. 2007 Sep;8 Suppl 1:S5-31. doi: 10.1007/s10198-007-0063-4. Eur J Health Econ. 2007. PMID: 17582539 Review.
The role of NICE technology appraisal in NHS rationing.
Walker S, Palmer S, Sculpher M. Walker S, et al. Br Med Bull. 2007;81-82:51-64. doi: 10.1093/bmb/ldm007. Epub 2007 Apr 4. Br Med Bull. 2007. PMID: 17409119 Review.

See all similar articles

Cited by

Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP).
Moradi N, Rashidian A, Rasekh HR, Olyaeemanesh A, Foroughi M, Mohammadi T. Moradi N, et al. Iran J Pharm Res. 2017 Spring;16(2):823-833. Iran J Pharm Res. 2017. PMID: 28979338 Free PMC article.
Close-Person Spill-Overs in End-of-Life Care: Using Hierarchical Mapping to Identify Whose Outcomes to Include in Economic Evaluations.
Canaway A, Al-Janabi H, Kinghorn P, Bailey C, Coast J. Canaway A, et al. Pharmacoeconomics. 2019 Apr;37(4):573-583. doi: 10.1007/s40273-019-00786-5. Pharmacoeconomics. 2019. PMID: 30877637
Guidelines for conducting and reporting economic evaluation of fall prevention strategies.
Davis JC, Robertson MC, Comans T, Scuffham PA. Davis JC, et al. Osteoporos Int. 2011 Sep;22(9):2449-59. doi: 10.1007/s00198-010-1482-0. Epub 2010 Nov 23. Osteoporos Int. 2011. PMID: 21104231
NICE's 2008 Methods Guide: sensible consolidation or opportunities missed?
Sculpher M. Sculpher M. Pharmacoeconomics. 2008;26(9):721-4. doi: 10.2165/00019053-200826090-00001. Pharmacoeconomics. 2008. PMID: 18767891 No abstract available.
Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial.
Atherton N, Bridle C, Brown D, Collins H, Dosanjh S, Griffiths F, Hennings S, Khan K, Lall R, Lyle S, McShane R, Mistry D, Nichols V, Petrou S, Sheehan B, Slowther AM, Thorogood M, Withers E, Zeh P, Lamb SE. Atherton N, et al. Trials. 2016 Mar 25;17:165. doi: 10.1186/s13063-016-1288-2. Trials. 2016. PMID: 27015659 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Pharmacoeconomics. 2008;26(9):745-51 - PubMed
1. Pharmacoeconomics. 2008;26(9):769-79 - PubMed
1. Pharmacoeconomics. 2008;26(9):781-98 - PubMed
1. Pharmacoeconomics. 2008;26(9):753-67 - PubMed
1. Pharmacoeconomics. 2008;26(9):733-44 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer